Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents with type 1 diabetes: results from a randomized, double-blind, controlled trial - Danne, T; Datz, N; Endahl, L (Pediatr Diabetes, 2008)
et al.